Correlation Between Irisin and Cognitive Functions in Alzheimer Dementia
Zusammenhang zwischen Irisin und kognitiven Funktionen bei Alzheimer-Demenz
Annals of Clinical and Translational Neurology · 2025-09 · 12 (9) · 1743-1752
DOI: 10.1002/acn3.70117 ↗Auf einen Blick
Bei Patient:innen mit biomarkergesicherter Alzheimer-Erkrankung waren die Irisin-Spiegel in Liquor und Serum niedriger als bei subjektiver Gedächtnisbeschwerde. Niedrigere Werte gingen mit besserer Kognition zusammen.
Fragestellung
Besteht bei Patient:innen mit biomarkergesicherter Alzheimer-Erkrankung ein Zusammenhang zwischen Irisin und multidomänenbezogener Kognition?
Methode
Irisin in Liquor und Serum wurde per Enzymimmunoassay in einer Kohorte mit AD, MCI und SMC gemessen und mit globaler und multidomänenbezogener Kognition korreliert.
Ergebnisse
AD: 82, MCI: 44, SMC: 20. Niedrigere Liquor- und Serum-Irisinwerte bei AD und MCI gegenüber SMC. Liquor-Irisin korrelierte mit globaler Kognition und mehreren Domänen; Serum zeigte ähnliche Zusammenhänge.
Schlussfolgerung der Autor:innen
Die Ergebnisse unterstreichen die zentrale Beteiligung von Irisin an der multidomänenbezogenen Kognition und deuten auf eine potenzielle Rolle als kognitiver Biomarker der AD-Progression hin.
Kernaussagen
- Niedrigere Irisinwerte in Liquor und Serum bei AD und MCI als bei SMC
- Liquor-Irisin korrelierte mit globaler Kognition und mehreren Domänen
- Serum-Irisin zeigte ähnliche Korrelationen wie Liquor-Irisin
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 25.06.2025. Verfasst von Patrizia Pignataro und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Biomedicine and Neuroscience (DiBraiN), University of Bari "A. Moro", Bari, Italy. Hauptthemen laut MEDLINE: Alzheimer Disease, Fibronectins, Cognitive Dysfunction, Cognition. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Regione Puglia and CNR for Tecnopolo per la Medicina di Precisione. D.G.R. n. 2117 of 21.11.2018 (CUP: B84I18000540002)-C.I.R.E.M.I.C. (Research Center of Exce…, Next Generation EU, in the context of the National Recovery and Resilience Plan, Investment PE8 - Project Age-It: "Ageing Well in an Ageing Society". This reso…, NextGenerationEU.
Themen: Demenz
Abstract (Originalsprache)
Objective
The myokine irisin, a recent positive mediator of exercise in the brain, shows neuroprotective functions against Alzheimer's disease (AD). The association between irisin and cognition has never been explored in a biologically defined cohort of patients. Thus, in the present study, we investigated the association of irisin with multidomain cognition in patients showing dementia‐related symptomatology.
Methods
Cerebrospinal fluid (CSF) and serum irisin levels were evaluated using enzyme‐linked immunoassays in a cohort of subjects with a confirmed biomarker evidence of AD, including AD ( n = 82), mild cognitive impairment (MCI, n = 44), and subjective memory complaint (SMC, n = 20) patients. The results of this analysis were correlated with global cognitive efficiency assessed by Mini‐Mental State Examination, and multidomain cognition evaluated by a battery of psychometric tests.
Results
Decreased CSF and serum irisin levels were observed in AD and MCI patients compared to SMC. A significant correlation has been found between irisin in the CSF and global cognitive efficiency, as well as with specific cognitive domains such as memory, executive functions, attention, visuospatial abilities, and language. For serum irisin, the correlation analysis evidenced similar results to those observed for the CSF.
Interpretation
Our results highlight the key involvement of irisin in multidomain cognition, indicating its potential role as a cognitive biomarker of AD progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational Biomedicine and Neuroscience (DiBraiN), University of Bari "A. Moro", Bari, Italy.
- Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari "A. Moro", Bari, Italy.
- Center for Neurodegenerative Diseases and the Aging Brain, University of Bari "A. Moro" at "pia Fondazione Card G. Panico" Hospital, Bari, Italy.
ORCID-Profile: Patrizia Pignataro, Silvia Colucci, Giancarlo Logroscino
Förderung
- Regione Puglia and CNR for Tecnopolo per la Medicina di Precisione. D.G.R. n. 2117 of 21.11.2018 (CUP: B84I18000540002)-C.I.R.E.M.I.C. (Research Center of Exce…
- Next Generation EU, in the context of the National Recovery and Resilience Plan, Investment PE8 - Project Age-It: "Ageing Well in an Ageing Society". This reso…
- NextGenerationEU
Zitieren
APA
Pignataro, P., Dicarlo, M., Zecca, C., Urso, D., Dell'Abate, M. T., Vilella, D., Borlizzi, F., Zerlotin, R., Oranger, A., Colaianni, G., Colucci, S., Grano, M., & Logroscino, G. (2025). Correlation Between Irisin and Cognitive Functions in Alzheimer Dementia. Annals of Clinical and Translational Neurology, 12(9), 1743-1752. https://doi.org/10.1002/acn3.70117
Vancouver
Pignataro P, Dicarlo M, Zecca C, Urso D, Dell'Abate MT, Vilella D, et al. Correlation Between Irisin and Cognitive Functions in Alzheimer Dementia. Annals of Clinical and Translational Neurology. 2025;12(9):1743-1752. doi:10.1002/acn3.70117
BibTeX
@article{Pignataro2025,
author = {Pignataro, Patrizia and Dicarlo, Manuela and Zecca, Chiara and Urso, Daniele and Dell'Abate, Maria Teresa and Vilella, Davide and Borlizzi, Francesco and Zerlotin, Roberta and Oranger, Angela and Colaianni, Graziana and Colucci, Silvia and Grano, Maria and Logroscino, Giancarlo},
title = {Correlation Between Irisin and Cognitive Functions in Alzheimer Dementia},
journal = {Annals of Clinical and Translational Neurology},
year = {2025},
volume = {12},
number = {9},
pages = {1743--1752},
doi = {10.1002/acn3.70117}
}
EUVIMED